- Lobbying
- Lobbying by Lexicon Pharmaceuticals, Inc
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Michael J. Bell | Special Asst to the Atty Gen - Legislative Affairs-DOJ (2003-2005); Dpty Assoc. Dir for Presidential Personnel-The White House (2001-2003); Staff Member-Sen Orrin G. Hatch (2000-2001); Staff Asst-US Senate, Comm on the Judiciary (1998-2000) Special Asst to the Atty Gen - Legislative Affairs-DOJ (2003-2005); Dpty Assoc. Dir for Presidential Personnel-The White House (2001-2003); Staff Member-Sen Orrin G. Hatch (2000-2001); Staff Asst-US Senate, Comm on the Judiciary (1998-2000) |
Kathleen M. McAuliffe | Counsel, House Democratic Leader Richard Gephardt (1995-2000) Counsel, House Democratic Leader Richard Gephardt 95-2000 |
Katherine King | Legislative Assistant, Congressman Tony Cardenas, 2013 - 2017 |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration
Issue(s) they said they’d lobby about: Issues associated with diabetes treatments.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate